Andersson DI, Hughes D. Evolution of antibiotic resistance at non-lethal drug concentrations[J]. Drug Resist Update, 2012（15）：162-172.
[2]
Bennett PM. Plasmid encoded antibiotic resistance：acquisition and transfer of antibiotic resistance genes in bacteria[J]. Br J Pharmacol, 2008, 153（S1）：S347-357.
[3]
Jalasvuori M, Friman VP, Nieminen A, et al. Bacteriophage selection against a plasmid-encoded sex apparatus leads to the loss of antibiotic-resistance plasmids[J]. Biol Lett, 2011（7）：902-905.
[4]
Dahlberg C, Chao L. Amelioration of the cost of conjugative plasmid carriage in Eschericha coli K12[J]. Genetics, 2003（165）：1641-1649.
Guenther S, Huwyler D, Richard S, et al. Virulent bacteriophage for efficient biocontrol of Listeria monocytogenes in ready-to-eat foods[J].Appl Environ Microbiol, 2009, 75（1）：93-100.
[8]
US. Food and Drug Administration, 2007. Agency response letter GRAS notice No. GRN 000218, viewed 11/09/2007[EB/OL] . http：//www.cfsan.fda.gov/~rdb/opa-g218.html.
Bush K, Courvalin P, Dantas G, et al. Tackling antibiotic resistance[J]. Nat Rev Microbiol, 2011（9）：894-906.
[15]
Krylov V, Shaburova O, Krylov S, Pleteneva E. A genetic approach to the development of new therapeutic phages to fight pseudomonas aeruginosa in wound infections[J]. Viruses, 2013（5）：15-53.
[16]
Clokie MR, Millard AD, Letarov AV, Heaphy S. Phages in nature[J]. Bacteriophage, 2011（1）：31-45.
[17]
Sechter I, Mestre F, Hansen DS. Twenty-three years of Klebsiella phage typing：a review of phage typing of 12 clusters of nosocomial infections, and a comparison of phage typing with K serotyping [J]. Clin Microbiol Infect, 2000（6）：233-238.
[18]
Dennehy JJ. What can phages tell us about host-pathogen Co-evolution? [J]. Int J Evol Biol, 2012（2012）：1-13.
[19]
Marston MF, Pierciey FJ Jr, Shepard A, et al. Rapid diversification of coevolving marine Synechococcus and a virus[J]. Proc Natl Acad Sci USA, 2012（109）：4544-4549.
[20]
Capparelli R, Nocerino N, Iannaccone M, et al. Bacteriophage therapy of Salmonella enterica：a fresh appraisal of bacteriophage therapy[J]. J Infect Dis, 2010（201）：52-61.
[21]
Orm?l? AM, Jalasvuori M. Phage therapy：should bacterial resistance to phages be a concern, even in the long run? [J].Bacteriophage, 2013, 3（1）：e24219.
[22]
Gómez P, Buckling A. Bacteria-phage antagonistic coevolution in soil[J]. Science, 2011（332）：106-109.
[23]
Meyer JR, Agrawal AA, Quick RT, et al. Parallel changes in host resistance to viral infection during 45, 000 generations of relaxed selection[J]. Evolution, 2010（64）：3024-3034.
[24]
Inal JM. Phage therapy：a reappraisal of bacteriophages as antibiotics[J]. Arch Immunol Ther Exp（Warsz）, 2003（51）：237-244.
[25]
Capparelli R, Nocerino N, Lanzetta R, et al. Bacteriophage resistant Staphylococcus aureus mutant confers broad immunity against staphylococcal infection in mice [J]. PLoS One, 2010（5）：e11720.
[26]
Filippov AA, Sergueev KV, He Y, et al. Bacteriophage-resistant mutants in Yersinia pestis：identification of phage receptors and attenuation for mice[J]. PLoS One, 2011（6）：e25486.
[27]
Wei Y, Ocampo P, Levin BR. An experimental study of the population and evolutionary dynamics of Vibrio cholerae O1 and the bacteriophage JSF4[J]. Proc Biol Sci, 2010（277）：3247-3254.
[28]
Flores CO, Meyer JR, Valverde S, et al. Statistical structure of host-phage interactions[J]. Proc Natl Acad Sci USA, 2011（108）：E288-297.
[29]
Wolf A, Wiese J, Jost G, Witzel KP. Wide geographic distribution of bacteriophages that lyse the same indigenous freshwater isolate（Sphingomonas sp. strain B18）[J]. Appl Environ Microbiol, 2003（69）：2395-2398.
[30]
Sulakvelidze A, Alavidze Z, Morris JG Jr. Bacteriophage therapy[J]. Antimicrob Agents Chemother, 2001（45）：649-659.
[31]
Denomy JB, Pawluk A, Maxwell KL, Davidson AR. Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system[J]. Nature, 2013（493）：429-432.
[32]
Seed KD, Lazinski DW, Calderwood SB, Camilli A. A bacteriophage encodes its own CRISPR/Cas adaptive response to evade host innate immunity[J]. Nature, 2013（494）：489-491.
